Academy of Science, Czech Republic Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03104036
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Academy of Science Czech Republic | Czech Academy of Sciences | Institute of Animal Physiology and Genetics Academy of Science Czech Republic

Active Ingredients

Drugs in Phase 2 Trials (2)

human fecal microbiota (Reybota) (1 trial)

mesalamine (rowasa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2